Double blind, placebo-controlled, efficacy and safety study of clobazam in patients with Lennox-Gastaut syndrome.
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2017
At a glance
- Drugs Clobazam (Primary)
- Indications Lennox-Gastaut syndrome
- Focus Registrational; Therapeutic Use
- Acronyms CONTAIN
- Sponsors Lundbeck Inc
- 05 Dec 2017 Results of post hoc analysis presented at the 71st Annual Meeting of the American Epilepsy Society.
- 05 Dec 2017 Results of a Population PK Modeling from Study 301, OV-1012 and OV-1017 studies presented at the 71st Annual Meeting of the American Epilepsy Society
- 28 Sep 2016 Results of post-hoc analysis from OV-1004 and OV-1012 studies (n=200) published in the Neurology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History